Metabolic Research
Tirzepatide
10 mgTirzepatide is a dual GIP and GLP-1 receptor agonist studied in metabolic research models involving glucose regulation, insulin response, appetite signaling, and body-weight-related endpoints.
Quantity
Estimated total
$90.00
About the Product
What the research says
Studied as a dual incretin receptor agonist targeting GIP and GLP-1 pathways.
Published clinical research has evaluated effects on glycemic control and body-weight-related outcomes.
Commonly discussed in metabolic research involving insulin sensitivity, appetite regulation, and energy balance.
Research use only notice
Tirzepatide is presented here strictly for laboratory research use and is not intended for human consumption, clinical use, diagnostic use, or therapeutic use.
Products listed by Valence Biologics are not intended for human consumption, clinical use, diagnostic use, therapeutic use, veterinary use, household use, or as food, drugs, cosmetics, or dietary supplements.
